Document is current
Any future updates will be listed below
-
Authors
File, Danielle M.
Pascual, Tomas
Deal, Allison M.
Wheless, Amy
Perou, Charles M.
Claire Dees, E.
Carey, Lisa A. https://orcid.org/0000-0003-2388-4649
-
Funding
Funding for this research was provided by:
National Cancer Institute (P50-CA58223)
Susan G. Komen
Breast Cancer Research Foundation
Sociedad Española de Oncología Médica
John William Pope Foundation
National Institutes of Health (T32)
- License Information
-
More Information
Article History
Received: 22 March 2022
Accepted: 31 July 2022
First Online: 25 August 2022
Declarations
:
: CMP is an equity stockholder and consultant of BioClassifier LLC; CMP is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay. The other authors report no disclosures in relation to this work.
: The study was approved by the institutional review board at the University of North Carolina Office of Human Research Ethics Institutional Review Board.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health, the NCI, or the other study sponsors. The funding agencies had no role in the design or conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.
